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Conference on “Emerging Infectious
Diseases: Meeting the Challenge”
Emerging infectious diseases, the leading cause
of death worldwide, continue to pose difficult chal-
lenges to clinicians, public health professionals, and
biomedical researchers in academic settings and
industry. Addressing these challenges requires a
cohesive effort to develop prevention strategies and
to communicate them effectively to the health care
community, the public, and policy makers.
On June 5-6, 1995, the New York Academy of
Medicine and the New York State Department of
Health convened to examine the problem of emerg-
ing infections. The speakers addressed four themes:
1) emerging infectious diseases: why and why now?
2) transmission of emerging infectious diseases: old
modes, new agents; 3) surveillance and sentinel
systems for infectious diseases; and 4) emerging
infectious diseases: what is to be done?
The first three themes were addressed through
presentations by 20 experts. The fourth was divided
into six segments focusing on diagnosis, the role of
the microbiology laboratory in surveillance, other
surveillance issues, approaches to epidemic investi-
gations, risk perception, and global issues.
Speakers consistently alluded to recent compla-
cency about infectious diseases in the United States
and stressed the need for the clinical, public health,
and research communities to work with the biomedi-
cal industry in confronting emerging infectious dis-
ease challenges in this era of transition to managed
health care. In his opening address Joshua Leder-
berg from Rockefeller University reminded partici-
pants that the struggle between humans and
microbes could be characterized as a battle of “wits
versus genes.” Margaret Hamburg, Commissioner
of the New York City Department of Health, empha-
sized that plague in India and Ebola virus infection
in Zaire were reminders that the world is a global
village, that considering domestic and international
diseases as separate entities is an outmoded con-
cept, and that many conditions that contribute to
disease emergence or reemergence in the developing
world are also present in the United States, adding
to our domestic vulnerability to emerging infections.
Other speakers focused on the evolution of viru-
lence, the molecular basis of pathogenesis, observa-
tions on factors contributing to the plague epidemic
in India in 1994 and the Ebola outbreak in Zaire in
1976; foodborne and waterborne diseases; airborne
diseases; zoonoses; sexually transmitted and blood-
borne diseases and the increasing problem of an-
timicrobial resistance in both hospital and
community settings. Concerns were expressed
about the possibility of a “post-antimicrobial era” in
which available drugs are no longer effective against
common bacterial infections. Other speakers fo-
cused on innovative approaches to surveillance at
the local, state, national, and international levels.
James LeDuc from the World Health Organization
(WHO) provided an update on the emerging infec-
tions resolution passed by the World Health Assem-
bly in May 1995 and other WHO activities related
to detecting and responding to emerging and ree-
merging diseases.
Among the themes recurring throughout the con-
ference were the challenges that microbes will con-
tinue to pose; the critical role of the modern
microbiology laboratory in detecting and responding
to emerging and reemerging infections; and the limi-
tations of existing capacity at the local, state, na-
tional, and international level to respond to these
challenges. Human resource, equipment, diagnostic
reagent, and facility needs were addressed, and re-
source needs were emphasized. Training needs of
medical students, clinicians, epidemiologists, micro-
biologists, entomologists, mammalogists, behav-
ioral scientists, and other researchers were also
stressed. Additional emphasis was placed on the
critical importance of communicating alerts about
clusters of illness, data on disease trends, and guide-
lines for disease prevention; the need for educating
professionals, the public, and policy makers about
the critical importance of these issues; the need for
strengthening existing partnerships and developing
new ones, particularly with health maintenance or-
ganizations, the pharmaceutical industry, and non-
governmental organizations (including medical
missionary organizations); and the need to carefully
identify priorities.
Conference participants resounded the message
of the 1992 Institute of Medicine Report, Emerging
Infections: Microbial Threats to Health in the United
States, “Pathogenic microbes can be resilient, dan-
gerous foes. Although it is impossible to predict their
individual emergence in time and place, we can be
confident that new microbial diseases will emerge.”
Particular future concerns included a possible influ-
enza pandemic, the emergence of vancomycin resis-
tance in Staphylococcus aureus, the occurrence of
large dengue hemorrhagic fever epidemics in the
Western Hemisphere, and the likelihood that addi-
tional chronic diseases will be found to have infec-
tious etiologies. Concerns were also expressed about
the possibility of a terrorist incident involving an
infectious agent and the potential difficulties in de-
tecting and responding to such an episode.
The New York Academy of Medicine plans to use
the discussions during the conference in formulating
an agenda for further action.
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Guidelines to Prevent Opportunistic
Infections in HIV-Infected Persons
U.S. Public Health Service (USPHS)/Infectious
Diseases Society of America (IDSA) Guidelines for
Preventing Opportunistic Infections in HIV-Infected
Persons will be published in an August 1995 supple-
ment of Clinical Infectious Diseases. The guidelines,
which are intended for health care providers, are the
result of collaboration between the Centers for Dis-
ease Control and Prevention (CDC), the National
Institutes of Health, IDSA, numerous federal and
nonfederal organizations, community groups, and
HIV-infected persons. The guidelines are endorsed
by the American Academy of Pediatrics, the Infec-
tious Diseases Society of Obstetrics and Gynecology,
and the Society of Healthcare Epidemiologists of
America. Jonathan E. Kaplan, M.D. (CDC), Henry
Masur, M.D. (NIH), and King Holmes, M.D., Ph.D.
(University of Washington), chaired the
USPHS/IDSA Prevention of Opportunistic Infec-
tions Working Group and are guest editors of the
Clinical Infectious Diseases supplement.
CDC initiated work on the guidelines in early
1994; meetings were held in Atlanta in June and
September to discuss and refine the recommenda-
tions.
The USPHS/IDSA guidelines address 17 oppor-
tunistic infections from three angles: 1) preventing
exposure to opportunistic pathogens (e.g., sexual,
occupational, and environmental exposure as well
as exposure through pets, food, water, and interna-
tional travel); 2) preventing opportunistic disease by
chemoprophylaxis and vaccination; and 3) prevent-
ing disease recurrence. In this document, new rec-
ommendations were made and earlier recommenda-
tions were updated. For example, new guidelines
recommend that in nonemergency situations, cyto-
megalovirus (CMV)-seronegative HIV-infected per-
sons who require blood transfusions receive only
Japanese Encephalitis Acquired
in Australia
Japanese encephalitis (JE), a mosquito-borne
flaviviral disease of humans and animals, is a major
public health problem in Asia, where an estimated
50,000 cases occur each year. There has been concern
that the range of epidemic JE may be expanding.
On April 5, 1995, an outbreak of three cases of JE
was recognized in Australia. Two of the cases were
fatal; all were among residents of an island in Aus-
tralia’s Torres Strait, which lies between mainland
Queensland and Papua New Guinea. JE was con-
firmed in two of the patients by polymerase chain
reaction (Jeffrey Hanna, Queensland Health, pers.
comm.). No other cases were reported. This is the
first recognized episode of JE acquired in Australia.
Control activities on the Australian island began
on April 7. The community was informed about the
importance of personal mosquito protection meas-
ures. In addition, larvicides were applied, and areas
were fogged to kill adult mosquitoes.
The patients were all male, aged 6 to 44 years. All
were hospitalized with symptoms that included fe-
ver (up to 40oC), stiff or painful neck, headache, and
abdominal pain. Two patients were unconscious at
the time of admission.
Acute-phase sera showed elevated JE virus im-
munoglobulin M (IgM) titers. Two of the patients
also had detectable levels of Kunjin and Murray
Valley encephalitis virus IgM, but the JE IgM titers
were significantly higher in each case.
Flaviviruses have also been isolated from the
sera of each of two asymptomatic island residents.
Preliminary tests suggest that these are both JE
virus. Blood taken from 10 horses and 12 domestic
pigs living near humans on the island was also
tested. All 12 pigs and 9 of the horses had high JE
titers by hemagglutination inhibition assay. Neu-
tralizing antibody to JE virus was detectable in all
the pigs and in four of the horses tested to date.
Details of the index case are as follows: The
patient, a 16-year-old male, was admitted to Thurs-
day Island Hospital on March 22, 1995. He was
unconscious and was responsive only to painful
stimuli. His neck was stiff, and he showed a prefer-
ence for moving his right side. His illness had begun
3 days before. The day before admission he com-
plained of abdominal pain. This patient had been
mildly mentally retarded since birth and occasionally
had generalized seizures but was generally healthy.
He was transferred to Cairns Base Hospital, where a
cerebral CT scan showed a nonenhancing hypodense
lesion in his posterior right basal ganglia.
He had a leukocytosis of 17.3 ´ 109L, neutrophils,
15.2  ´ 109. His cerebrospinal fluid contained 150
leukocytes/ml with a differential count of 50% poly-
morphs and 50% mononuclear cells.
He had a generalized seizure and 2 days after
admission, required mechanical ventilation. He
never regained consciousness and died on day 17 of
hospitalization (April 8).
Adapted from Hanna J, Ritchie S, Loewenthal M,
et al. Probable Japanese encephalitis acquired in
the Torres Strait. Communicable Diseases Intelli-
gence 1995;19:206-7.
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